Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Sickle Cell Disease

Transplantation of unrelated placental blood cells in children with high-risk sickle cell disease

Summary:

The lack of healthy HLA-identical sibs limits the use of allogeneic hematopoietic cell transplantation in children with high-risk sickle cell disease (SCD). We evaluated unrelated placental blood cell transplantation (UPBCT) after a preparative regimen of busulfan, cyclophosphamide and antithymocyte globulin in three children with SCD who had cerebrovascular accidents (CVAs) and did not have HLA-matched sib donors. The placental blood cell units were matched with the recipients at four of six HLA-A, HLA-B and HLA-DRB1 antigens. Neutrophil levels above 0.5 × 109/l occurred at 23, 38 and 42 days after UPBCT, and platelet levels above 50 × 109/l without transfusions occurred at 62, 81 and 121 days after UPBCT. All patients developed acute graft-versus-host disease (GVHD; two grade II, one grade III), and one developed extensive chronic GVHD. One patient had graft failure and autologous hematopoietic recovery. Two patients have complete donor hematopoietic chimerism without detectable hemoglobin S or symptoms of SCD at 40 and 61 months, respectively, after UPBCT. These observations demonstrate the feasibility of UPBCT in children with SCD. Further studies of UPBCT for SCD are needed but, because of risks of procedure-related morbidity and graft rejection, should be restricted to pediatric patients with high-risk manifestations of SCD.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Fixler J, Styles L . Sickle cell disease. Pediatr Clin N Amer 2002; 49: 1193–1210.

    Article  Google Scholar 

  2. Platt OS, Brambilla DJ, Rosse WF et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994; 330: 1639–1644.

    Article  CAS  PubMed  Google Scholar 

  3. Powars D, Wilson B, Imbus C et al. The natural history of stroke in sickle cell disease. Am J Med 1978; 65: 461–471.

    Article  CAS  PubMed  Google Scholar 

  4. Balkaran B, Char G, Morris JS et al. Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr 1992; 120: 360–366.

    Article  CAS  PubMed  Google Scholar 

  5. Ohene-Frempong K, Weiner SJ, Sleeper LA et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998; 91: 288–294.

    CAS  PubMed  Google Scholar 

  6. Wang WC, Kovnar EH, Tonkin IL et al. High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease. J Pediatr 1991; 118: 377–382.

    Article  CAS  PubMed  Google Scholar 

  7. Pegelow CH, Adams RJ, McKie V et al. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr 1995; 26: 896–899.

    Article  Google Scholar 

  8. Harmatz P, Butensky E, Quirolo K et al. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy. Blood 2000; 96: 76–79.

    CAS  PubMed  Google Scholar 

  9. Ballas SK . Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease. Semin Hematol 2001; 38 (Suppl. 1): 30–36.

    Article  CAS  PubMed  Google Scholar 

  10. Vichinsky EP, Luban NL, Wright E et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001; 41: 1086–1092.

    Article  CAS  PubMed  Google Scholar 

  11. Rosse WF, Gallagher D, Kinney TR et al. Transfusion and alloimmunization in sickle cell disease. Blood 1990; 76: 1431–1437.

    CAS  PubMed  Google Scholar 

  12. Vichinsky EP, Earles A, Johnson RA et al. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990; 322: 1617–1621.

    Article  CAS  PubMed  Google Scholar 

  13. Bernaudin F, Souillet G, Vannier JP et al. Bone marrow transplantation (BMT) in 14 children with severe sickle cell disease (SCD): the French experience. Bone Marrow Transplant 1993; 12 (Suppl. 1): 118–121.

    PubMed  Google Scholar 

  14. Vermylen C, Cornu G, Ferster A et al. Bone marrow transplantation in sickle cell disease: the Belgian experience. Bone Marrow Transplant 1993; 12 (Suppl. 1): 116–117.

    PubMed  Google Scholar 

  15. Walters MC, Patience M, Leisenring W et al. Bone marrow transplantation for sickle cell disease. N Engl J Med 1996; 335: 369–376.

    Article  CAS  PubMed  Google Scholar 

  16. Abboud MR, Kletzel M, Miller S et al. Bone marrow transplantation for sickle cell disease (abstract). Blood 1997; 90: 229a.

    Google Scholar 

  17. Bernaudin F, Souillet G, Vannier JP et al. Report of the French experience concerning 26 children transplanted for severe sickle cell disease. Bone Marrow Transplant 1997; 19 (Suppl. 2): 112–115.

    Google Scholar 

  18. Vermylen C, Cornu G, Ferster A et al. Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplant 1998; 22: 1–6.

    Article  CAS  PubMed  Google Scholar 

  19. Walters MC, Storb R, Patience M et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Blood 2000; 95: 1918–1924.

    CAS  PubMed  Google Scholar 

  20. Vichinsky EP, Neumayr LD, Earles AN et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. N Engl J Med 2000; 342: 1855–1865.

    Article  CAS  PubMed  Google Scholar 

  21. Locatelli F, Rocha V, Reed W et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 2003; 101: 2137–2143.

    Article  CAS  PubMed  Google Scholar 

  22. Walters MC, Patience M, Leisenring W et al. Barriers to bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant 1996; 2: 100–104.

    CAS  PubMed  Google Scholar 

  23. Walters MC, Patience M, Leisenring W et al. Collaborative multicenter investigation of marrow transplantation for sickle cell disease: current results and future directions. Biol Blood Marrow Transplant 1997; 3: 310–315.

    CAS  PubMed  Google Scholar 

  24. Kurtzberg J, Laughlin M, Graham ML et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996; 335: 157–166.

    Article  CAS  PubMed  Google Scholar 

  25. Gluckman E, Rocha V, Boyer-Chammard A et al. Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med 1997; 337: 373–381.

    Article  CAS  PubMed  Google Scholar 

  26. Rubinstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 1565–1577.

    Article  CAS  PubMed  Google Scholar 

  27. Rocha V, Wagner Jr JE, Sobocinski KA et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. N Engl J Med 2000; 342: 1846–1854.

    Article  CAS  PubMed  Google Scholar 

  28. Laughlin MJ, Barker J, Bambach B et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344: 1815–1822.

    Article  CAS  PubMed  Google Scholar 

  29. Rocha V, Cornish J, Sievers EL et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001; 97: 2962–2971.

    Article  CAS  PubMed  Google Scholar 

  30. Barker JN, Davies SM, DeFor TE et al. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 2001; 97: 2957–2961.

    Article  CAS  PubMed  Google Scholar 

  31. Wagner JE, Barker JN, DeFor TE et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611–1618.

    CAS  PubMed  Google Scholar 

  32. Grewal SS, Barker JN, Davies SM, Wagner JE . Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood 2003; 101: 4233–4244.

    Article  CAS  PubMed  Google Scholar 

  33. Adamkiewicz TV, Hsu LL, Rubinstein P et al. Feasibility of identification of unrelated placental/umbilical cord blood cell units for transplantation in patients with high-risk sickle cell disease. Blood 1998; 92: 162a (abstract).

    Google Scholar 

  34. Krishnamurti L, Abel S, Maiers M, Flesch S . Availability of unrelated donors for hematopoietic stem cell transplantation for hemoglobinopathies. Bone Marrow Transplant 2003; 31: 547–550.

    Article  CAS  PubMed  Google Scholar 

  35. Marcus RE, Goldman JM . Convulsions due to high-dose busulfan. Lancet 1984; 2: 1463.

    Article  CAS  PubMed  Google Scholar 

  36. Rubinstein P, Dobrila L, Rosenfield RE et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 1995; 92: 10119–10122.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Scharf SJ, Smith AG, Hansen JA et al. Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers. Blood 1995; 85: 1954–1963.

    CAS  PubMed  Google Scholar 

  38. Przepiorka D, Weisdorf D, Martin P et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825–828.

    CAS  PubMed  Google Scholar 

  39. Sullivan KM, Agura E, Anasetti C et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991; 28: 250–259.

    CAS  PubMed  Google Scholar 

  40. Lansky SB, List MA, Lansky LL et al. The measurement of performance in childhood cancer patients. Cancer 1987; 60: 1651–1656.

    Article  CAS  PubMed  Google Scholar 

  41. Beatty PG, Boucher KM, Mori M, Milford EL . Probability of finding HLA-mismatched related or unrelated marrow or cord blood donors. Human Immunol 2000; 61: 834–840.

    Article  CAS  Google Scholar 

  42. Scothorn DJ, Price C, Schwartz D et al. Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr 2002; 140: 348–354.

    Article  PubMed  Google Scholar 

  43. Ware RE, Zimmerman SA, Schultz WH . Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease. Blood 1999; 94: 3022–3026.

    CAS  PubMed  Google Scholar 

  44. Steen RG, Helton KJ, Horwitz EM et al. Improved cerebrovascular patency following therapy in patients with sickle cell disease: initial results in 4 patients who received HLA-identical hematopoietic stem cell allografts. Ann Neurol 2001; 49: 222–229.

    Article  CAS  PubMed  Google Scholar 

  45. Adamkiewicz TV, Chiang KY, Haight A et al. Significant progression of large central nervous system (CNS) vessel disease following full matched sibling marrow engraftment in a child with Hg SS, National Sickle Cell Disease Program 25th Annual Meeting 2002; Vol. 1 (abstract).

  46. Kalinyak KA, Morris C, Ball WS et al. Bone marrow transplantation in a young child with sickle cell anemia. Am J Hematol 1995; 48: 256–261.

    Article  CAS  PubMed  Google Scholar 

  47. Anasetti C, Amos D, Beatty PG et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 1989; 320: 197–204.

    Article  CAS  PubMed  Google Scholar 

  48. Charache S, Terrin ML, Moore RD et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995; 332: 1317–1322.

    Article  CAS  PubMed  Google Scholar 

  49. Steinberg MH, Barton F, Castro O et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA 2003; 289: 1645–1651.

    Article  CAS  PubMed  Google Scholar 

  50. Vichinsky EP . Current issues with blood transfusions in sickle cell disease. Semin Hematol 2001; 38: 14–22.

    Article  CAS  PubMed  Google Scholar 

  51. Nisbet-Brown E, Olivieri NF, Giardina PJ et al. Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial. Lancet 2003; 361: 1597–1602.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by grants from the National Institutes of Health, Bethesda, MD (K23 HL04251) (TVA), (R01 CA40282 and U10 CA20549) (AMY), and by grants from the Emory Medical Care Foundation (TVA), the Phil Niekro Egleston Celebrity Classic/Jill Andrews Leukemia Research Fund (AMY), the Andrew McLeroy Memorial Research Fund (AMY), the Armstead-Barnhill Foundation for Sickle Cell Anemia Research (AMY) and the Stott Research Fund in Honor of Alex Jensen (AMY).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A M Yeager.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adamkiewicz, T., Mehta, P., Boyer, M. et al. Transplantation of unrelated placental blood cells in children with high-risk sickle cell disease. Bone Marrow Transplant 34, 405–411 (2004). https://doi.org/10.1038/sj.bmt.1704606

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704606

Keywords

This article is cited by

Search

Quick links